Home/Filings/4/0001144204-16-113597
4//SEC Filing

Fortress Biotech, Inc. 4

Accession 0001144204-16-113597

$FBIOCIK 0001429260operating

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 5:23 PM ET

Size

8.3 KB

Accession

0001144204-16-113597

Insider Transaction Report

Form 4
Period: 2016-07-15
Klein Dov
Director
Transactions
  • Disposition to Issuer

    Common Stock, par value $0.001

    2016-07-1513,333141,667 total
  • Award

    Deferred Restricted Stock Units

    2016-07-15+13,33313,333 total
    Common Stock (13,333 underlying)
Holdings
  • Common Stock, par value $0.001

    (indirect: By Spouse)
    1,800
Footnotes (2)
  • [F1]The Reporting Person was granted 50,000 shares of restricted common stock of the Issuer in July 2015 for his service on the Issuer's Board of Directors. The shares vest one-third annually beginning on July 15, 2016. The Reporting Person deferred the receipt of 80% of the vested shares and, on July 15, 2016, received instead 13,333 shares of deferred restricted stock units pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). As a result, the Reporting Person is reporting the disposition of 13,333 shares of Issuer common stock in exchange for an equal number of deferred restricted stock units.
  • [F2]Each deferred restricted stock unit will be settled in one share of the Issuer's common stock at the time and in the matter set forth in the Plan.

Issuer

Fortress Biotech, Inc.

CIK 0001429260

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001429260

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 5:23 PM ET
Size
8.3 KB